戻る Agenda
Poster Presentations and Networking Reception
Session Chair(s)
![Session Chair Invited](/_Images/member/Generic_Image_Missing-Profile.jpg)
Session Chair Invited
Manager
DIA, United States
Poster Presentations and Networking Reception
Speaker(s)
![Michelle Hellstern, BSN](/_Images/member/Generic_Image_Missing-Profile.jpg)
Redaction Impact and Efficiencies Assessed for Optimal Transparency Preparation for the EU Clinical Trial Regulation 536/2014
Michelle Hellstern, BSN
CSL Behring, United States
Manager, Clinical Trial Disclosure & Transparency
![Raina Agarwal, MPharm](/_Images/member/Generic_Image_Missing-Profile.jpg)
Assessment of Anonymization Methods, Processes, and Challenges for Clinical Information Submissions to Health Canada
Raina Agarwal, MPharm
Kinapse Ltd, A Syneos Health Company, United States
Senior Manager
Do You Know Your Risk?
Cathal Gallagher
d-wise, United Kingdom
TAG Member & Transparency Lead
Experiences Generating Synthetic Clinical Trial Data
Lucy Mosquera, MSc
Replica Analytics, Canada
Senior Director, Data Science
![Veera Thota](/_Images/member/Generic_Image_Missing-Profile.jpg)
Automating Data Anonymization Procedures with Software
Veera Thota
MMS Holdings, United States
Actionable Insights for Plain Language Summary Implementation
Pooja Phogat, PhD
Krystelis Ltd., India
Co-founder and Co-CEO
![Nirpal Virdee, MSc](/_Images/member/Generic_Image_Missing-Profile.jpg)
The Future of Transparency: How Global Regulatory Authorities May Expect Patient and HCP Engagement During the Drug Approval Process
Nirpal Virdee, MSc
Certara, United Kingdom
Head, Transparency & Disclosure